These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 16650406
1. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator. Radosevich M, Jager M, Ono SJ. Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406 [Abstract] [Full Text] [Related]
2. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ. Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139 [Abstract] [Full Text] [Related]
3. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells. Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K. Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734 [Abstract] [Full Text] [Related]
4. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G. Cell Growth Differ; 2001 Jun 25; 12(6):327-35. PubMed ID: 11432807 [Abstract] [Full Text] [Related]
5. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA. Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL. Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198 [Abstract] [Full Text] [Related]
10. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells. Rigaud G, De Lerma Barbaro A, Nicolis M, Cestari T, Ramarli D, Riviera AP, Accolla RS. J Immunol; 1996 Jun 01; 156(11):4254-8. PubMed ID: 8666795 [Abstract] [Full Text] [Related]
12. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. Lian RH, Kotwal GJ, Wellhausen SR, Hunt LA, Justus DE. J Immunol; 1996 Jul 15; 157(2):864-73. PubMed ID: 8752940 [Abstract] [Full Text] [Related]
13. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice. Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD. Mol Immunol; 2007 Mar 15; 44(7):1709-21. PubMed ID: 16982097 [Abstract] [Full Text] [Related]
14. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. Sartoris S, Tosi G, De Lerma Barbaro A, Cestari T, Accolla RS. Eur J Immunol; 1996 Oct 15; 26(10):2456-60. PubMed ID: 8898960 [Abstract] [Full Text] [Related]
15. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N. J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831 [Abstract] [Full Text] [Related]
16. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV, Osawa H, Arnett HA, Háskova Z, George AJ, Ono SJ, Ting JP, Streilein JW. Eur J Immunol; 2004 Feb 15; 34(2):471-80. PubMed ID: 14768052 [Abstract] [Full Text] [Related]
17. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells. Meissner M, Whiteside TL, Kaufmann R, Seliger B. Arch Dermatol Res; 2009 Feb 15; 301(2):189-93. PubMed ID: 19104823 [Abstract] [Full Text] [Related]
18. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. Lee YJ, Han Y, Lu HT, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN. J Immunol; 1997 Mar 01; 158(5):2065-75. PubMed ID: 9036950 [Abstract] [Full Text] [Related]
19. CIITA transformation rescues the apoptotic function of MHC class II in melanoma cells. Le E, Zhang H, Blanck G. Anticancer Res; 2005 Mar 01; 25(6B):3889-92. PubMed ID: 16312044 [Abstract] [Full Text] [Related]
20. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells. Morimoto Y, Toyota M, Satoh A, Murai M, Mita H, Suzuki H, Takamura Y, Ikeda H, Ishida T, Sato N, Tokino T, Imai K. Br J Cancer; 2004 Feb 23; 90(4):844-52. PubMed ID: 14970863 [Abstract] [Full Text] [Related] Page: [Next] [New Search]